"Long Island Digestive Disease Consultants is one of the largest and most medically advanced gastroenterology practices on long Island. We have been serving Suffolk County for nearly forty years. Our eight board certified physicians and three nurse practitioners are highly skilled, dedicated and experienced in all areas of gastroenterology, and provide comprehensive care in a warm and caring environment. All of the medical professionals at Long Island Digestive Disease Consultants have extensive training and experience, and remain updated about the newest advances in gastrointestinal health and treatment through continuing medical education."

During the past decade, Gastrointestinal Research Associates, LLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastrointestinal Research Associates, LLC" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Gastrointestinal Research Associates, LLC" are "Chronic Constipation" (1 trials), "Crohn's Disease" (1 trials), "Diarrhea Predominant Irritable Bowel Syndrome" (1 trials), "Irritable Bowel Syndrome With Constipation" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Gastrointestinal Research Associates, LLC" in a lesser frequency.

Most popular intervention types in "Gastrointestinal Research Associates, LLC" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "vedolizumab" (2 trials), "Asimadoline" (1 trials) and "Linaclotide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gastrointestinal Research Associates, LLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Gastrointestinal Research Associates, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Gastrointestinal Research Associates, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gastrointestinal Research Associates, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".